← Open Payments lookup

JOAN SHEPHERD: Open Payments

NPI 1689838294 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,759 in 80 payments from 16 companies in 2025. Trend: 2023 $29 · 2024 $766 · 2025 $1,759

Food & beverage: $1,759
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$370
Vanda Pharmaceuticals Inc.16$326
ABBVIE INC.14$206
Alkermes, Inc.11$196
Axsome Therapeutics, Inc.4$173
E.R. Squibb & Sons, L.L.C.5$162
Otsuka America Pharmaceutical, Inc.7$133
Teva Pharmaceuticals USA, Inc.2$34
IDORSIA PHARMACEUTICALS US INC2$33
TMS NeuroHealth Centers Inc.2$25

Products named: CAPLYTA, FANAPT, VRAYLAR, ARISTADA, Auvelity, COBENFY, REXULTI, ABILIFY ASIMTUFII.

Industry payments across VA — which companies pay providers there.